TrialLupus science & medicine2025

Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report.

Mieke van Schaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.